Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Neuhaus 2009

Methods RCT
enrolled: 96
evaluated: 96
Participants histologically proven lung cancer (small cell or nonsmall cell)
18‐75 years of age
at least one measurable lesion in the brain
sufficient bone marrow reserve, renal function tests
ECOG performance status 0‐2
excluded leptomeningeal metastases
Interventions whole brain radiation alone
versus
whole brain radiation and topotecan
Outcomes response rate
progression‐free survival
overall survival
quality of life
Notes